Efficacy of obesity in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations: A Turkish Oncology Group Study

被引：0
|
作者：
Artac, M. [1 ]
Korkmaz, L. [2 ]
Coskun, H. [3 ]
Dane, F. [4 ]
Karabulut, B. [5 ]
Karaagac, M. [2 ]
Cabuk, D. [6 ]
Karabulut, S. [7 ]
Aykan, F. [7 ]
Doruk, H. [8 ]
Avci, N. [9 ]
Turhal, S. [10 ]
机构：
[1] Necmettin Erbakan Univ, Meram Med Fac, Med Oncol, Konya, Turkey
[2] Necmettin Erbakan Univ, Med Oncol, Konya, Turkey
[3] Akdeniz Univ Med Oncol, Med Oncol, Antalya, Turkey
[4] Marmara Univ Hosp, Med Oncol, Istanbul, Turkey
[5] Ege Univ, Sch Med, Tulay Aktas Oncol, Izmir, Turkey
[6] Kocaeli Univ, Med Oncol, Kocaeli, Turkey
[7] Istanbul Univ, Inst Oncol, Med Oncol, Istanbul, Turkey
[8] Acibadem Bursa Hosp, Med Oncol, Bursa, Turkey
[9] Ali Osman Sonmez Oncol Hosp, Med Oncol & Hematol Clin, Med Oncol, Bursa, Turkey
[10] Anadolu Hlth Ctr, Med Oncol, Istanbul, Turkey
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw370.82
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
534P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer
    Tamura, Shingo
    Kusaba, Hitoshi
    Kubo, Naoki
    Ijichi, Kayo
    Tsuchihashi, Kenji
    Komoda, Masato
    Uchino, Keita
    Ariyama, Hiroshi
    Akashi, Koichi
    Baba, Eishi
    MEDICAL ONCOLOGY, 2014, 31 (03)
  • [22] Efficacy and Toxicity of Addition of Bevacizumab to Chemotherapy in Patients with Metastatic Colorectal Cancer
    Ruan, Wen-Cong
    Che, Yue-Ping
    Ding, Li
    Li, Hai-Feng
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2018, 21 (10) : 718 - 724
  • [23] Association of morphologic response with overall survival in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy: Updated analysis-HGCSG0802
    Yagisawa, M.
    Yuki, S.
    Muranaka, T.
    Sawada, K.
    Hatanaka, K.
    Kato, T.
    Meguro, T.
    Nakamura, M.
    Iwanaga, I.
    Eto, K.
    Sato, A.
    Okuda, H.
    Kato, K.
    Miyagishima, T.
    Muto, O.
    Yabusaki, S.
    Miyamoto, N.
    Kudo, K.
    Sakata, Y.
    Komatsu, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S361 - S362
  • [24] Efficacy and safety of bevacizumab-based maintenance therapy in metastatic colorectal cancer A meta-analysis
    Ma, Hongbo
    Wu, Xiaoli
    Tao, Miaomiao
    Tang, Nan
    Li, Yanyan
    Zhang, Xianquan
    Zhou, Qi
    MEDICINE, 2019, 98 (50)
  • [25] Bevacizumab-Based Chemotherapy Combined with Regional Deep Capacitive Hyperthermia in Metastatic Cancer Patients: A Pilot Study
    Ranieri, Girolamo
    Ferrari, Cristina
    Di Palo, Alessandra
    Marech, Ilaria
    Porcelli, Mariangela
    Falagario, Gianmarco
    Ritrovato, Fabiana
    Ramunni, Luigi
    Fanelli, Margherita
    Rubini, Giuseppe
    Gadaleta, Cosmo Damiano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (07)
  • [26] Instability of non standard microsatellites in metastatic colorectal cancer patients treated with a bevacizumab based chemotherapy
    Pirini, Francesca
    Pasini, Luigi
    Ravaioli, Sara
    Tedaldi, Gianluca
    Scarpi, Emanuela
    Marisi, Giorgia
    Molinari, Chiara
    Calistri, Daniele
    Passardi, Alessandro
    Ulivi, Paola
    CANCER RESEARCH, 2020, 80 (16)
  • [27] Evaluation of two-dimensional response to predict overall survival in patients with metastatic colorectal cancer treated with the first-line bevacizumab-based chemotherapy
    Nakayama, Goro
    Takano, Nao
    Tanaka, Chie
    Kobayashi, Daisuke
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [28] Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?
    Grothey, A
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (01): : 22 - 23
  • [29] Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice
    Rossi, Luigi
    Veltri, Enzo
    Zullo, Angelo
    Zoratto, Federica
    Colonna, Maria
    Di Seri, Marisa
    Longo, Flavia
    Mottolese, Marcella
    Giannarelli, Diana
    Ruco, Luigi
    Romiti, Adriana
    Barucca, Viola
    Adua, Daniela
    Tomao, Silverio
    FUTURE ONCOLOGY, 2012, 8 (09) : 1193 - 1197
  • [30] The impact of Th17 cell pathway-related genetic variants in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy.
    Tokunaga, Ryuma
    Cao, Shu
    Puccini, Alberto
    Naseem, Madiha
    Battaglin, Francesca
    Barzi, Afsaneh
    Millsteinand, Joshua
    Soni, Shivani
    Berger, Martin D.
    McSkane, Michelle
    Zhang, Wu
    Loupakis, Fotios
    Cremolini, Chiara
    Falcone, Alfredo
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345